Keywords: Hospira, Hydromorphone, Product recall, USA, FDA

Hospira recalls hydromorphone pain product on overdose concerns

Article | 20 August 2012

Print This

USA-based Hospira (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, last week initiated a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in